Table 1.
Socio-demographic, vaccination, and sexually transmitted infection characteristics among 16–23-year-old persons with a diagnosis of gonococcal mono-infection or chlamydial mono-infection — New York City and Philadelphia (2016–2018), N=96,235 persons (134,983 STI episodes)
| Variable | N | % |
|---|---|---|
| Race/ethnicity | ||
| Black, non-Hispanic | 35,419 | 36.8 |
| Hispanic | 14,666 | 15.2 |
| Other1 | 7,890 | 8.2 |
| White, non-Hispanic | 5,085 | 5.3 |
| Missing | 33,175 | 34.5 |
| Gender | ||
| Male | 32,428 | 33.7 |
| Female | 63,751 | 66.3 |
| Transgender | 26 | <1.0 |
| Missing | 30 | <1.0 |
| Ever received MenB-FHbp vaccine | ||
| Yes2 | 1,500 | 1.6 |
| No | 94,735 | 98.4 |
| Jurisdiction | ||
| New York City | 64,718 | 67.2 |
| Philadelphia | 31,517 | 32.8 |
1
Asian, American Indian, Native Hawaiian/Pacific Islander, other race, or two or more races
2
Receipt of ≥1 dose of MenB-FHbp vaccine